Update on TNF Inhibitors.

Update on TNF Inhibitors. Semin Cutan Med Surg. 2016 Jun;35(4S):S67-S70 Authors: Kerdel FA Abstract The introduction of tumor necrosis factor (TNF)-α inhibitors dramatically improved the management of psoriasis. Some newer or investigational biologics with different mechanisms of action have demonstrated noninferiority or superiority to etanercept, the first self-injectable anti-TNF-α agent to become available in the United States. Nonetheless, TNF-α inhibitors are likely to remain a mainstay of therapy for many years. Semin Cutan Med Surg 35(supp4):S67-S70. PMID: 27526035 [PubMed - as supplied by publisher]
Source: Seminars in Cutaneous Medicine and Surgery - Category: Dermatology Tags: Semin Cutan Med Surg Source Type: research